SCHEMBL26127971

SCHEMBL26127971

CCN(C)C1CN(c2ncc(Br)cc2[N+](=O)[O-])C1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ OPRK1 P41145 9/20 0.34
▸ JAK2 O60674 2/20 0.34
▸ JAK3 P52333 2/20 0.34
▸ JAK1 P23458 1/20 0.34
▸ NOS3 P29474 1/20 0.32
▸ NOS1 P29475 1/20 0.32
▸ NOS2 P35228 1/20 0.32
▸ CXCR3 P49682 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ CCR6 P51684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29969671 1.00 ALDH1A1 (0.40) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL22941968 0.88 ALDH1A1 (0.43) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL29968653 0.85 ALDH1A1 (0.36) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL26130136 0.85 ALDH1A1 (0.36) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL26130281 0.82 ALDH1A1 (0.39) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL29969938 0.82 ALDH1A1 (0.40) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL26131044 0.82 ALDH1A1 (0.40) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL29968129 0.81 JAK2 (0.43) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL26130781 0.81 JAK2 (0.43) ALDH1A1MAPK1HTTOPRK1JAK2
SCHEMBL29968199 0.79 HRH3 (0.34) OPRK1JAK2JAK3JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4327877-A2 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRad Therapeutics, Inc. (US) 2024-02-28 — — EP disclosed
EP-4327877-A2 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRad Therapeutics, Inc. (US) 2024-02-28 — — EP disclosed
EP-3784671-B1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS INC (US) 2023-10-11 — — EP disclosed
EP-3784671-B1 DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY XRAD THERAPEUTICS INC (US) 2023-10-11 — — EP disclosed
Send feedback